Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
about
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patientsTaurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusionsAntibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancerAntibiotic and other lock treatments for tunnelled central venous catheter related infections in children with cancerTaurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wallOral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.Vascular catheter-associated infections: a microbiological and therapeutic update.Central venous catheter-associated Nocardia bacteremia in cancer patients.Phytochemical Profiling of Leaf, Stem, and Tuber Parts of Solena amplexicaulis (Lam.) Gandhi Using GC-MSTwenty-five years of advances in vascular access: bridging research to clinical practice.Antibiotic-lock therapy for long-term catheter-related bacteremia: a review of the current evidence.Microbial and Antibiotic Susceptibility Profile among Clinical Samples of Patients with Acute LeukemiaDefining bloodstream infections related to central venous catheters in patients with cancer: a systematic review.Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns.Rescue therapy of difficult-to-treat indwelling central venous catheter-related bacteremias in cancer patients: a review for practical purposes.Antibiotic-lock therapy: a clinical viewpoint.Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells.Gene expression analysis of cell death induction by taurolidine in different malignant cell linesComparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.Oral administration of taurolidine ameliorates chronic DSS colitis in mice.Efficacy of Taurolidine Irrigation in Primary Total Knee Arthroplasty.
P2860
Q21261533-A434A291-EAA3-49FE-9C74-E9473E0A90C0Q21559450-EC8C8ECC-E02F-43FA-9889-8E04CF7360E4Q24201815-6E0D1510-6E25-4B83-B2BE-53FB9EFDA810Q24234319-67CAC958-F2BE-4CDC-8571-7074BF4C7F6AQ33529088-B5AEA887-5292-4788-9D52-882301A27862Q33822115-8E89F248-83A1-42F8-BA75-1E836C7A5C2AQ34585059-297830A0-CECF-48D3-A22B-9FE342AA3F7AQ35877503-A471C497-D490-4417-BD17-347662A3ACC1Q36068055-FAA773CD-6ECA-46C6-99A6-76FAF918FBFDQ36321489-C4D284B6-7F46-43A7-A41C-9B7E8F28D503Q36901951-B512B3F8-BCCF-4A31-A5E8-B95FE2ACD5DBQ36954375-BE4AF3F2-9D4A-48C4-8205-7F5B6CAEB4C9Q37926303-D707B032-317F-41A8-A6F2-9E127EEF8AB6Q38020228-29A6F935-786B-4F94-91B1-E8CE44476D0AQ38081494-C3486236-1863-4E7C-A3DE-37E6C25A5596Q38168929-489028DD-7795-4429-AE69-CF9775500DD2Q38960699-BE3B4684-CFBC-44ED-93F2-83090F76AEE0Q39062925-70F9A073-46A2-4D05-AF19-BBE7068B2415Q39638401-86D249D8-6147-40A0-806C-BDB9333E73CCQ39731870-AB746C2C-B2A2-4870-991E-8227A843CE7CQ42956960-0453525C-3A3D-4396-B620-B8AD8BC67C15Q46922561-3E05F795-20DE-4576-A3B2-B8F9ADF2CC72Q55008445-D0287284-07A8-4291-9F49-83699926D6B0
P2860
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Taurolidine is effective in th ...... infections in cancer patients.
@ast
Taurolidine is effective in th ...... infections in cancer patients.
@en
Taurolidine is effective in th ...... infections in cancer patients.
@nl
type
label
Taurolidine is effective in th ...... infections in cancer patients.
@ast
Taurolidine is effective in th ...... infections in cancer patients.
@en
Taurolidine is effective in th ...... infections in cancer patients.
@nl
prefLabel
Taurolidine is effective in th ...... infections in cancer patients.
@ast
Taurolidine is effective in th ...... infections in cancer patients.
@en
Taurolidine is effective in th ...... infections in cancer patients.
@nl
P1476
Taurolidine is effective in th ...... infections in cancer patients.
@en
P2093
Koldehoff M
Zakrzewski JL
P304
P356
10.1016/J.IJANTIMICAG.2004.06.006
P577
2004-11-01T00:00:00Z